查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1301048

宏基因組學市場規模、份額和趨勢分析報告：按技術（鳥槍測序、16S 測序、全基因組測序）、按產品、按工作流程、按應用、按地區和細分市場趨勢：2023-2030 年

Metagenomics Market Size, Share & Trends Analysis Report By Technology (Shotgun Sequencing, 16S Sequencing, Whole Genome Sequencing), By Product, By Workflow, By Application, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

宏基因組學市場增長和趨勢

根據 Grand View Research, Inc. 的最新報告，到 2030 年，全球宏基因組學市場預計將達到 40.2 億美元。

從 2023 年到 2030 年，市場預計將以 14.8% 的複合年增長率擴張。 基因組學和蛋白□□質組學研究的興起、個性化藥物的日益採用以及對生物製劑的需求不斷增長正在推動對測序儀的需求，從而促進該行業的增長。 例如，2022 年 8 月，Illumina, Inc. 宣布計劃通過開發解決方案中心來擴大其在巴西的基因組學業務。 新設施是臨床基因組學需求不斷增長並加速公司在拉丁美洲的足蹟的結果。

公司增加研發投資預計將對宏基因組學在許多應用中的使用產生重大影響。 例如，2021年4月，安捷倫科技公司收購了Resolution Bioscience, Inc.，一家基於NGS的精準腫瘤學解決方案開發商。 Resolution Bioscience 的非侵入性液體活檢平台與安捷倫基於組織的伴隨診斷技術的結合預計將擴大安捷倫在精準腫瘤學 NGS 技術領域的市場地位。

廣泛採用宏基因組學進行環境應用的另一個因素是微生物直接參與生物地球化學循環。 微生物對石油碳氫化合物等碳源的降解促使研究人員研究生物燃料生產的宏基因組學過程。 此外，未培養的微生物中存在許多未被發現的生物分子，加速了宏基因組學在農業、食品安全、化學、工業和其他相關應用中的採用。

自 COVID-19 爆發以來，生命科學和生物技術行業的主要利益相關者正在尋求跟蹤、檢測和治療 COVID-19 的解決方案。 宏基因組分析在病毒檢測和追蹤中發揮著重要作用。 已經部署了各種序列監測平台和解決方案來有效診斷感染。 例如，2021年5月，牛津大學和甲骨文宣佈建立戰略合作夥伴關係，開發強大的基於雲的基因組測序和分析平台，以降低冠狀病毒感染的風險。

此外，政府為促進學術機構使用 NGS 平台進行研究而提供的資金將進一步增加宏基因組學工具的使用。 例如，2021 年 2 月，加拿大政府投資 5300 萬美元實施多層方法診斷 COVID-19。 加拿大政府計劃利用基因組測序和分析技術來實現預期結果。

宏基因組學生成的數據質量也是增加分析成本的因素之一。 數據質量很大程度上取決於測序過程中的平均運行次數。 高質量的分析是有代價的。 然而，由於 RNA-Seq 等新技術的準確性、快速結果和價格下降，其採用正在迅速增加。 據觀察，測序成本每年增加5-10倍，計算能力每兩年增加一倍。

宏基因組市場報告亮點

  • 按產品劃分，試劑盒和試劑細分市場佔有最大的市場份額。 對這些產品的批量需求很高。 試劑盒和試劑的高市場滲透率進一步推動了高收入份額。
  • 從技術角度來看，鳥槍測序領域預計將在預測期內佔據最大份額，且複合年增長率最快。 讀取樣本中所有基因組 DNA 的能力等優勢賦予了該技術競爭優勢，導致研究人員越來越多地採用鳥槍法測序。
  • 從應用來看，臨床診斷領域預計將在整個預測期內實現最快的複合年增長率。 旨在利用測序技術開發個性化療法的研究舉措預計將影響和推動臨床研究領域的增長。
  • 按工作流程劃分，2022 年測序細分市場所佔份額最大。 除了採用簡單的工作流程模型、對快速結果的需求以及與推動測序和數據分析服務需求的系統價格相比，每個樣本的分析成本較低之外。
  • 由於專注於基因組研究的大公司和大型研究和學術機構已建立營銷和分銷網絡，北美在 2022 年將主導全球宏基因組學行業。
  • 主要公司包括 Illumina.Inc.、Thermo Fisher Scientific, Inc.、QIAGEN 和 Promega Corporation。

內容

第一章調查方法及範圍

  • 市場細分和範圍
  • 市場定義
    • 信息分析
    • 市場形成和數據可視化
    • 驗證和發布數據
  • 調查假設
  • 信息獲取
    • 初步調查
  • 信息或數據分析
  • 市場形成和驗證
  • 市場模式
  • 全球市場：計算複合年增長率
  • 目的

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第三章市場變量、趨勢和範圍

  • 市場體系展望
    • 母公司市場前景
    • 相關/補充市場前景
  • 市場趨勢和展望
  • 市場動態
    • 降低測序成本
    • 生物技術和生物信息技術的發展
    • 人們對各種研究的微生物篩查越來越感興趣
    • 基因組學新領域的出現補充了宏基因組學
  • 市場製約因素分析
    • 對計算和各種分析工具的訪問有限
    • 宏基因組學的總成本很高
  • 商業環境分析
    • SWOT 分析；按因素（政治/法律、經濟/技術）
    • 波特五力分析
  • 新型冠狀病毒病 (COVID-19) 的影響分析

第 4 章技術業務分析

  • 宏基因組市場：技術波動分析
  • 霰彈槍序列
    • 鳥槍法測序市場，2018-2030 年（百萬美元）
  • 16S序列
    • 2018-2030 年 16S 測序市場（百萬美元）
  • 全基因組測序
    • 2018-2030 年全基因組測序市場（百萬美元）
  • 其他
    • 其他市場，2018-2030 年（百萬美元）

第五章產品業務分析

  • 宏基因組學市場：產品變異分析
  • 試劑盒和試劑
    • 試劑盒和試劑市場，2018-2030 年（百萬美元）
  • 測序和數據分析服務
    • 2018-2030 年測序和數據分析服務市場（百萬美元）
  • 軟件
    • 2018-2030 年軟件市場（百萬美元）

第 6 章：應用程序業務分析

  • 宏基因組市場：應用的變異分析
  • 環境應用
    • 2018-2030 年環境應用市場（百萬美元）
  • 臨床診斷應用
    • 2018-2030 年臨床診斷應用市場（百萬美元）
  • 藥物發現應用
    • 2018-2030 年藥物發現應用市場（百萬美元）
  • 生物技術的應用
    • 2018-2030 年生物技術應用市場（百萬美元）
  • 食品和營養應用
    • 2018-2030 年食品和營養應用市場（百萬美元）
  • 其他
    • 其他市場，2018-2030 年（百萬美元）

第七章工作流程業務分析

  • 宏基因組學市場：工作流程變異分析
  • 前序
    • 2018-2030 年預測序市場（百萬美元）
  • 序列
    • 測序市場，2018-2030 年（百萬美元）
  • 數據分析
    • 2018-2030 年數據分析市場（百萬美元）

第 8 章區域業務分析

  • 2022 年和 2030 年按地區劃分的宏基因組市場份額
  • 北美
    • SWOT分析
    • 北美宏基因組學市場，2018-2030 年（百萬美元）
    • 美國
    • 加拿大
  • 歐洲
    • SWOT分析
    • 2018-2030 年歐洲宏基因組市場（百萬美元）
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • SWOT分析
    • 2018-2030 年亞太宏基因組市場（百萬美元）
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳大利亞
    • 泰國
  • 拉丁美洲
    • SWOT分析
    • 拉丁美洲宏基因組市場，2018-2030 年（百萬美元）
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • SWOT分析
    • MEA 宏基因組學市場，2018-2030 年（百萬美元）
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特

第 9 章競爭格局

  • 公司分類
  • 戰略規劃
  • 公司簡介/列表
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc..
    • PerkinElmer, Inc.
    • Promega Corporation
    • Oxford Nanopore Technologies
    • Qiagen
    • Takara Bio, Inc.
    • Novogene Co., Ltd.
    • F. Hoffmann-La Roche Ltd.
Product Code: GVR-2-68038-452-9

Metagenomics Market Growth & Trends

The global metagenomics market size is expected to reach USD 4.02 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.8% from 2023 to 2030. The increasing research in genomics and proteomics, the rising adoption of personalized medicines, and escalating requirement for biologic products are driving the demand for sequencing, fueling the growth of the industry. For instance, in August 2022, Illumina, Inc. announced its plans to expand genomics operations in Brazil by developing a solution center. The establishment of the new facility is the result of rising demand for clinical genomics and accelerating the company's footprint in Latin America.

A boost in R&D investments by the players is estimated to have a considerable impact on the usage of metagenomics in numerous applications. For instance, in April 2021, Agilent Technologies, Inc. acquired Resolution Bioscience, Inc., an NGS-based precision oncology solution developing company. The combination of Resolution Bioscience's noninvasive liquid biopsy platform with Agilent's tissue-based companion diagnostics is anticipated to expand Agilent's market position in NGS technologies for precision oncology.

Another factor contributing to the high adoption of metagenomics for environmental use is the direct involvement of microorganisms in the biogeochemical cycle. The degradation of carbon sources such as petroleum hydrocarbons by microbes has encouraged researchers to study metagenomics processes for the production of biofuels. In addition, the presence of a large number of undiscovered biomolecules in non-cultured microorganisms accelerated the adoption of metagenomics in agriculture, food safety, chemical, industrial, and other related applications.

Since the outbreak of COVID-19, key stakeholders in the life sciences and biotechnology industry are seeking solutions for COVID-19 tracking, detection, and treatment. Metagenomics analysis plays a crucial role in the detection and tracing of the virus. Various sequencing surveillance platforms and solutions are being deployed for effective diagnosis of infection. For instance, in May 2021, Oxford University and Oracle announced a strategic partnership to develop robust cloud-based genomic sequencing and analysis platform to mitigate the risk of coronavirus infection.

Moreover, funds provided by the government for promoting research in academic institutes, which use NGS platforms, further increase the usage of metagenomics tools. For instance, in February 2021, the Canadian government invested USD 53 million to implement a multilayered approach for the diagnosis of COVID-19. The Canadian government will utilize genome sequencing and analysis technologies to achieve desired outcomes.

The quality of data generated through metagenomics is another factor that increases the cost of analysis. The quality of data is highly dependent on the average number of times the bases are run during the sequencing process. The high-quality analysis is expensive. However, the adoption of emerging novel techniques, such as RNA-Seq, is rapidly increasing owing to accuracy and rapid results along with a decline in prices. It is observed that the cost of sequencing falls 5 to 10 times every year and the value of computing power doubles every two years.

Metagenomics Market Report Highlights

  • By product, the kits & reagents segment accounts for the largest market share. The demand in terms of volumes is high for these products. High market penetration of kits and reagents further contributes toward their highest revenue share
  • By technology, the shotgun sequencing segment is estimated to have the largest share with the fastest CAGR over the forecast period. The advantages such as the ability to read all genomic DNA in a sample give a competitive edge to the technology resulting in the growing adoption of shotgun sequencing among researchers
  • By application, the clinical diagnostics segment is anticipated to have the fastest CAGR throughout the forecast period. Owing to the research initiatives for the development of personalized therapies using sequencing technology are expected to impact growth in the area of clinical research, hence, propelling the growth
  • By workflow, the sequencing segment held the largest share in 2022, owing to the adoption of easy workflow models, demand for rapid results, and lower cost of per sample analysis compared to the price of systems driving the demand for sequencing & data analytics services
  • North America dominated the global metagenomics industry in 2022 owing to the presence of well-established marketing and distribution network of major companies and large-sized research & academic institutes, which focus on genomic studies
  • A few of the key players include Illumina. Inc.; Thermo Fisher Scientific, Inc.; QIAGEN; and Promega Corporation

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Information analysis
    • 1.2.2. Market formulation & data visualization
    • 1.2.3. Data validation & publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Declining expenses of sequencing
    • 3.3.2. Developments in biotechnology & bioinformatics techniques
    • 3.3.3. Rising interest in microbial screening for different investigations
    • 3.3.4. Emergence of new fields in genomics that complement metagenomics
  • 3.4. Market Restraint Analysis
    • 3.4.1. Limited accessibility to computation and different analytic tools
    • 3.4.2. High overall cost of metagenomics
  • 3.5. Business Environment Analysis
    • 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.5.2. Porter's Five Forces Analysis
  • 3.6. COVID - 19 Impact Analysis

Chapter 4. Technology Business Analysis

  • 4.1. Metagenomics market: Technology Movement Analysis
  • 4.2. Shotgun Sequencing
    • 4.2.1. Shotgun Sequencing Market, 2018 - 2030 (USD Million)
  • 4.3. 16S Sequencing
    • 4.3.1. 16S Sequencing Market, 2018 - 2030 (USD Million)
  • 4.4. Whole Genome Sequencing
    • 4.4.1. Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Product Business Analysis

  • 5.1. Metagenomics market: Product Movement Analysis
  • 5.2. Kits and Reagents
    • 5.2.1. Kits and Reagents Market, 2018 - 2030 (USD Million)
  • 5.3. Sequencing & Data Analytics Services
    • 5.3.1. Sequencing & Data Analytics Services Market, 2018 - 2030 (USD Million)
  • 5.4. Software
    • 5.4.1. Software Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Metagenomics market: Application Movement Analysis
  • 6.2. Environmental Application
    • 6.2.1. Environmental Application Market, 2018 - 2030 (USD Million)
  • 6.3. Clinical Diagnostics Applications
    • 6.3.1. Clinical Diagnostics Applications Market, 2018 - 2030 (USD Million)
  • 6.4. Drug Discovery Applications
    • 6.4.1. Drug Discovery Applications Market, 2018 - 2030 (USD Million)
  • 6.5. Biotechnology Applications
    • 6.5.1. Biotechnology Applications Market, 2018 - 2030 (USD Million)
  • 6.6. Food & Nutrition Applications
    • 6.6.1. Food & Nutrition Applications Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Workflow Business Analysis

  • 7.1. Metagenomics market: Workflow Movement Analysis
  • 7.2. Pre - sequencing
    • 7.2.1. Pre - sequencing Market, 2018 - 2030 (USD Million)
  • 7.3. Sequencing
    • 7.3.1. Sequencing Market, 2018 - 2030 (USD Million)
  • 7.4. Data Analysis
    • 7.4.1. Data Analysis Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Metagenomics market Share By Region, 2022 & 2030
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Metagenomics market, 2018 - 2030 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Competitive Scenario
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Target Disease Prevalence
      • 8.2.3.5. U.S. Metagenomics market, 2018 - 2030 (USD Million)
    • 8.2.4. Canada
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Competitive Scenario
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Target Disease Prevalence
      • 8.2.4.5. Canada Metagenomics market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. SWOT Analysis
    • 8.3.2. Europe Metagenomics market, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Target Disease Prevalence
      • 8.3.3.5. Germany Metagenomics market, 2018 - 2030 (USD Million)
    • 8.3.4. UK
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Target Disease Prevalence
      • 8.3.4.5. UK Metagenomics market, 2018 - 2030 (USD Million)
    • 8.3.5. France
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Competitive Scenario
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Target Disease Prevalence
      • 8.3.5.5. France Metagenomics market, 2018 - 2030 (USD Million)
    • 8.3.6. Italy
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Competitive Scenario
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Target Disease Prevalence
      • 8.3.6.5. Italy Metagenomics market, 2018 - 2030 (USD Million)
    • 8.3.7. Spain
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Competitive Scenario
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Target Disease Prevalence
      • 8.3.7.5. Spain Metagenomics market, 2018 - 2030 (USD Million)
    • 8.3.8. Denmark
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Competitive Scenario
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Target Disease Prevalence
      • 8.3.8.5. Denmark Metagenomics market, 2018 - 2030 (USD Million)
    • 8.3.9. Sweden
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Competitive Scenario
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Target Disease Prevalence
      • 8.3.9.5. Sweden Metagenomics market, 2018 - 2030 (USD Million)
    • 8.3.10. Norway
      • 8.3.10.1. Key Country Dynamics
      • 8.3.10.2. Competitive Scenario
      • 8.3.10.3. Regulatory Framework
      • 8.3.10.4. Target Disease Prevalence
      • 8.3.10.5. Norway Metagenomics market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. SWOT Analysis
    • 8.4.2. Asia Pacific Metagenomics market, 2018 - 2030 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Target Disease Prevalence
      • 8.4.3.5. Japan Metagenomics market, 2018 - 2030 (USD Million)
    • 8.4.4. China
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Target Disease Prevalence
      • 8.4.4.5. China Metagenomics market, 2018 - 2030 (USD Million)
    • 8.4.5. India
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Target Disease Prevalence
      • 8.4.5.5. India Metagenomics market, 2018 - 2030 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Target Disease Prevalence
      • 8.4.6.5. South Korea Metagenomics market, 2018 - 2030 (USD Million)
    • 8.4.7. Australia
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Target Disease Prevalence
      • 8.4.7.5. Australia Metagenomics market, 2018 - 2030 (USD Million)
    • 8.4.8. Thailand
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Target Disease Prevalence
      • 8.4.8.5. Thailand Metagenomics market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. SWOT Analysis
    • 8.5.2. Latin America Metagenomics market, 2018 - 2030 (USD Million)
    • 8.5.3. Brazil
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Target Disease Prevalence
      • 8.5.3.5. Brazil Metagenomics market, 2018 - 2030 (USD Million)
    • 8.5.4. Mexico
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Target Disease Prevalence
      • 8.5.4.5. Mexico Metagenomics market, 2018 - 2030 (USD Million)
    • 8.5.5. Argentina
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Target Disease Prevalence
      • 8.5.5.5. Argentina Metagenomics market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. SWOT Analysis
    • 8.6.2. MEA Metagenomics market, 2018 - 2030 (USD Million)
    • 8.6.3. South Africa
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Target Disease Prevalence
      • 8.6.3.5. South Africa Metagenomics market, 2018 - 2030 (USD Million)
    • 8.6.4. Saudi Arabia
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Target Disease Prevalence
      • 8.6.4.5. Saudi Arabia Metagenomics market, 2018 - 2030 (USD Million)
    • 8.6.5. UAE
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Target Disease Prevalence
      • 8.6.5.5. UAE Metagenomics market, 2018 - 2030 (USD Million)
    • 8.6.6. Kuwait
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Target Disease Prevalence
      • 8.6.6.5. Kuwait Metagenomics market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Profiles/Listing
    • 9.3.1. Illumina, Inc.
      • 9.3.1.1. Overview
      • 9.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Thermo Fisher Scientific, Inc.
      • 9.3.2.1. Overview
      • 9.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Bio - Rad Laboratories, Inc..
      • 9.3.3.1. Overview
      • 9.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. PerkinElmer, Inc.
      • 9.3.4.1. Overview
      • 9.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Promega Corporation
      • 9.3.5.1. Overview
      • 9.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Oxford Nanopore Technologies
      • 9.3.6.1. Overview
      • 9.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Qiagen
      • 9.3.7.1. Overview
      • 9.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Takara Bio, Inc.
      • 9.3.8.1. Overview
      • 9.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Novogene Co., Ltd.
      • 9.3.9.1. Overview
      • 9.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. F. Hoffmann - La Roche Ltd.
      • 9.3.10.1. Overview
      • 9.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 4 Global Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 5 Global Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 7 Global Metagenomics Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Metagenomics Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 10 North America Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 North America Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 12 North America Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 13 U.S. Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 14 U.S. Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 15 U.S. Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 16 U.S. Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 17 Canada Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 18 Canada Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 19 Canada Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 20 Canada Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 21 Europe Metagenomics Market, by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 23 Europe Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 24 Europe Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 25 Europe Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 26 Germany Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 27 Germany Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 28 Germany Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 29 Germany Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 30 UK Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 31 UK Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 UK Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 UK Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 34 France Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 35 France Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 36 France Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 37 France Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 38 Italy Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 39 Italy Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 40 Italy Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 41 Italy Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 42 Spain Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 43 Spain Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 44 Spain Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 45 Spain Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 46 Denmark Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 47 Denmark Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 48 Denmark Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 Denmark Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 50 Norway Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 51 Norway Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 Norway Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 53 Norway Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 54 Sweden Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 55 Sweden Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 56 Sweden Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 57 Sweden Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Metagenomics Market, by Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 63 China Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 64 China Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 65 China Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 66 China Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 67 Japan Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 68 Japan Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 69 Japan Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 70 Japan Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 71 India Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 72 India Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 India Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 74 India Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 75 South Korea Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 76 South Korea Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 South Korea Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 South Korea Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 79 Australia Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 80 Australia Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 81 Australia Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 82 Australia Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 83 Latin America Metagenomics Market, by Country, 2018 - 2030 (USD Million)
  • Table 84 Thailand Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 85 Thailand Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 86 Thailand Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 87 Thailand Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 88 Latin America Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 89 Latin America Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 90 Latin America Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 91 Latin America Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 92 Brazil Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 93 Brazil Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 94 Brazil Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 95 Brazil Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 96 Mexico Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 97 Mexico Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 98 Mexico Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 99 Mexico Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 100 Argentina Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 101 Argentina Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 102 Argentina Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 103 Argentina Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Metagenomics Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 109 South Africa Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 110 South Africa Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 111 South Africa Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 112 South Africa Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 117 UAE Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 118 UAE Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 119 UAE Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 120 UAE Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Metagenomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Metagenomics Market, by Application, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Metagenomics Market, Workflow, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain - Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Metagenomics, Market Segmentation
  • Fig. 8 Market Snapshot, 2021
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 16 Global Metagenomics Market: Technology Movement Analysis
  • Fig. 17 Global Metagenomics Market, for Shotgun Sequencing, 2018 - 2030 (USD Million)
  • Fig. 18 Global Metagenomics Market, for 16S Sequencing, 2018 - 2030 (USD Million)
  • Fig. 19 Global Metagenomics Market, for Whole Genome Sequencing, 2018 - 2030 (USD Million)
  • Fig. 20 Global Metagenomics Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 21 Global Metagenomics Market: Product Movement Analysis
  • Fig. 22 Global Metagenomics Market, for Kits & Reagents, 2018 - 2030 (USD Million)
  • Fig. 23 Global Metagenomics Market, for Sequencing & Data Analytics Services, 2018 - 2030 (USD Million)
  • Fig. 24 Global Metagenomics Market, for Software, 2018 - 2030 (USD Million)
  • Fig. 25 Global Metagenomics Market: Application Movement Analysis
  • Fig. 26 Global Metagenomics Market, for Environmental, 2018 - 2030 (USD Million)
  • Fig. 27 Global Metagenomics Market, for Clinical Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 28 Global Metagenomics Market, for Drug Discovery, 2018 - 2030 (USD Million)
  • Fig. 29 Global Metagenomics Market, for Biotechnology, 2018 - 2030 (USD Million)
  • Fig. 30 Global Metagenomics Market, for Food & Nutrition, 2018 - 2030 (USD Million)
  • Fig. 31 Global Metagenomics Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 32 Global Metagenomics Market: Workflow Movement Analysis
  • Fig. 33 Global Metagenomics Market, for Pre - sequencing, 2018 - 2030 (USD Million)
  • Fig. 34 Global Metagenomics Market, for Sequencing, 2018 - 2030 (USD Million)
  • Fig. 35 Global Metagenomics Market, for Data Analysis, 2018 - 2030 (USD Million)
  • Fig. 36 Regional Marketplace: Key Takeaways
  • Fig. 37 Regional Outlook, 2021 & 2030
  • Fig. 38 Global Metagenomics Market: Region Movement Analysis
  • Fig. 39 North America Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 42 Europe Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 44 UK Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 45 France Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 46 Italy Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 47 Spain Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 49 Norway Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 53 China Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 54 India Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 60 Mexico Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 62 Middle East and Africa Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 65 UAE Metagenomics Market, 2018 - 2030 (USD Million)
  • Fig. 66 Kuwait Metagenomics Market, 2018 - 2030 (USD Million)